Piper Jaffray Starts BridgeBio Pharma (BBIO) at Overweight
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Price: $79.86 -1.66%
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Jaffray analyst Tyler Van Buren initiates coverage on BridgeBio Pharma (NASDAQ: BBIO) with a Overweight rating and a price target of $50.00.
For an analyst ratings summary and ratings history on BridgeBio Pharma click here. For more ratings news on BridgeBio Pharma click here.
Shares of BridgeBio Pharma closed at $27.51 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BridgeBio Pharma (BBIO) PT Raised to $106 at Canaccord
- Evercore ISI Starts Alvotech SA (ALVO) at Outperform
- BridgeBio Pharma (BBIO) PT Raised to $111 at JPMorgan
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
